Matches in Wikidata for { <http://www.wikidata.org/entity/Q81753029> ?p ?o ?g. }
Showing items 1 to 58 of
58
with 100 items per page.
- Q81753029 description "article scientifique publié en 2005" @default.
- Q81753029 description "artículu científicu espublizáu en mayu de 2005" @default.
- Q81753029 description "scientific article published on 01 May 2005" @default.
- Q81753029 description "wetenschappelijk artikel" @default.
- Q81753029 description "наукова стаття, опублікована в травні 2005" @default.
- Q81753029 name "Phase 1 clinical and pharmacokinetics evaluation of oral CI-1033 in patients with refractory cancer" @default.
- Q81753029 name "Phase 1 clinical and pharmacokinetics evaluation of oral CI-1033 in patients with refractory cancer" @default.
- Q81753029 type Item @default.
- Q81753029 label "Phase 1 clinical and pharmacokinetics evaluation of oral CI-1033 in patients with refractory cancer" @default.
- Q81753029 label "Phase 1 clinical and pharmacokinetics evaluation of oral CI-1033 in patients with refractory cancer" @default.
- Q81753029 prefLabel "Phase 1 clinical and pharmacokinetics evaluation of oral CI-1033 in patients with refractory cancer" @default.
- Q81753029 prefLabel "Phase 1 clinical and pharmacokinetics evaluation of oral CI-1033 in patients with refractory cancer" @default.
- Q81753029 P1433 Q81753029-5F0505A1-E646-42CF-9ADF-FE3711371465 @default.
- Q81753029 P1476 Q81753029-6CC783A1-8FC1-4049-BE7D-A6B0EE190C0E @default.
- Q81753029 P2093 Q81753029-20A32A09-32CE-455E-96B2-5CE37C74269D @default.
- Q81753029 P2093 Q81753029-5476C59D-0E5C-41FA-90DA-2F41B2179C50 @default.
- Q81753029 P2093 Q81753029-922EDCB8-7789-40CC-8E48-EF4337618182 @default.
- Q81753029 P2093 Q81753029-9F1FC026-6D14-4704-A9B4-9CE5ED9E1A62 @default.
- Q81753029 P2093 Q81753029-A9D959A1-6485-4FFA-86E5-EED13DBC6885 @default.
- Q81753029 P2093 Q81753029-CA953D2A-1E38-40C9-A10B-26E82F36F447 @default.
- Q81753029 P2093 Q81753029-CA9EE39F-FCBB-4845-A927-A35D628C671E @default.
- Q81753029 P2093 Q81753029-D86954C5-96D6-41F7-BDD4-971C539D4B38 @default.
- Q81753029 P2093 Q81753029-EDA3E946-A148-4CCB-9A2E-116735B30310 @default.
- Q81753029 P2093 Q81753029-F6C20031-DF7C-43B5-8DB9-418941D5A22A @default.
- Q81753029 P2093 Q81753029-FDD02981-E96B-444D-AE7B-00395D779AF9 @default.
- Q81753029 P304 Q81753029-1E1B63BC-5954-4934-814E-0169E924EEFC @default.
- Q81753029 P31 Q81753029-A9068054-E381-4D39-B54B-307D8091FE70 @default.
- Q81753029 P356 Q81753029-C028B61C-D3B3-4D12-BEEF-15B6F7456B42 @default.
- Q81753029 P433 Q81753029-5C49EC11-1210-4C8E-AA34-3551E9632213 @default.
- Q81753029 P478 Q81753029-FCA676BB-1526-4730-A230-99DAE3E2F774 @default.
- Q81753029 P50 Q81753029-285E3317-1131-4F0D-B966-0BA9D067AB11 @default.
- Q81753029 P577 Q81753029-5C7BEF60-85F5-4476-B4CC-C3492508FAAE @default.
- Q81753029 P698 Q81753029-869C6738-E3D2-4E4A-8498-F2F785B9FD8B @default.
- Q81753029 P921 Q81753029-B878F82A-1E73-4703-B9A3-05640C9C3546 @default.
- Q81753029 P356 1078-0432.CCR-04-1950 @default.
- Q81753029 P698 15897585 @default.
- Q81753029 P1433 Q332253 @default.
- Q81753029 P1476 "Phase 1 clinical and pharmacokinetics evaluation of oral CI-1033 in patients with refractory cancer" @default.
- Q81753029 P2093 "Adrienne Williams" @default.
- Q81753029 P2093 "Casey Cunningham" @default.
- Q81753029 P2093 "Dong M Shin" @default.
- Q81753029 P2093 "Irene Eiseman" @default.
- Q81753029 P2093 "Michael Schlicht" @default.
- Q81753029 P2093 "Neil Senzer" @default.
- Q81753029 P2093 "Paul Bycott" @default.
- Q81753029 P2093 "Peter F Lenehan" @default.
- Q81753029 P2093 "Ralph G Zinner" @default.
- Q81753029 P2093 "Rebecca Zentgraff" @default.
- Q81753029 P2093 "Stephen C Olson" @default.
- Q81753029 P304 "3846-3853" @default.
- Q81753029 P31 Q13442814 @default.
- Q81753029 P356 "10.1158/1078-0432.CCR-04-1950" @default.
- Q81753029 P433 "10" @default.
- Q81753029 P478 "11" @default.
- Q81753029 P50 Q95970217 @default.
- Q81753029 P577 "2005-05-01T00:00:00Z" @default.
- Q81753029 P698 "15897585" @default.
- Q81753029 P921 Q323936 @default.